Literature DB >> 7544250

Human monoclonal antibodies for the immunological characterization of a highly conserved protein domain of the hepatitis C virus glycoprotein E1.

K Siemoneit1, M da S Cardoso, K Koerner, A Wölpl, B Kubanek.   

Abstract

Although both envelope glycoproteins of the hepatitis C virus, E1 and E2/NS1, show a high degree of sequence variation, the E1 protein includes a well conserved domain, which may be functionally important. We have analysed the human B cell response to a peptide fragment from amino acid residues 314-330 (EP3) covering the central conserved sequence of this domain. Anti-hepatitis C virus-positive blood donors were screened for anti-EP3 antibodies with an ELISA based on immobilized peptide. Thirty out of 92 (32%) RIBA-confirmed donors displayed a significant antibody response to EP3. From three of these blood donors we established four anti-EP3-producing heterohybridoma cell lines: Ul/F30 and Ul/F31 produced IgM-kappa, whereas Ul/F32 and Ul/F33 secreted the isotypes IgG1-lambda and IgG1-kappa, respectively. Epitope analysis with overlapping nonapeptides suggests the existence of different antigenic determinants within the EP3 fragment. Although both IgG antibodies Ul/F32 and Ul/F33 have dissociation constants to the peptide of approximately 10(-9) M, binding to recombinant E1 protein expressed in COS-7 cells was different. Only Ul/F33 detected envelope protein of approximately 24-35 kD in Western blot. This human MoAb will be useful for further investigations on the hepatitis C virus glycoprotein E1.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7544250      PMCID: PMC1553251          DOI: 10.1111/j.1365-2249.1995.tb08351.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  29 in total

1.  Nucleotide sequence of core and envelope genes of the hepatitis C virus genome derived directly from human healthy carriers.

Authors:  K Takeuchi; Y Kubo; S Boonmar; Y Watanabe; T Katayama; Q L Choo; G Kuo; M Houghton; I Saito; T Miyamura
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

2.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

3.  Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis.

Authors:  M Hijikata; N Kato; Y Ootsuyama; M Nakagawa; K Shimotohno
Journal:  Proc Natl Acad Sci U S A       Date:  1991-07-01       Impact factor: 11.205

Review 4.  Epitope mapping of flavivirus glycoproteins.

Authors:  F X Heinz
Journal:  Adv Virus Res       Date:  1986       Impact factor: 9.937

5.  Mouse x human heterohybridomas as fusion partners with human B cell tumors.

Authors:  W L Carroll; K Thielemans; J Dilley; R Levy
Journal:  J Immunol Methods       Date:  1986-05-01       Impact factor: 2.303

Review 6.  Hepatitis C virus: the major causative agent of viral non-A, non-B hepatitis.

Authors:  Q L Choo; A J Weiner; L R Overby; G Kuo; M Houghton; D W Bradley
Journal:  Br Med Bull       Date:  1990-04       Impact factor: 4.291

7.  Identification of an immunodominant epitope within the capsid protein of hepatitis C virus.

Authors:  M S Nasoff; S L Zebedee; G Inchauspé; A M Prince
Journal:  Proc Natl Acad Sci U S A       Date:  1991-06-15       Impact factor: 11.205

8.  At least 12 genotypes of hepatitis C virus predicted by sequence analysis of the putative E1 gene of isolates collected worldwide.

Authors:  J Bukh; R H Purcell; R H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

9.  Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein.

Authors:  B Hosein; C T Fang; M A Popovsky; J Ye; M Zhang; C Y Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-01       Impact factor: 11.205

10.  Transmissible agent in non-A, non-B hepatitis.

Authors:  H J Alter; R H Purcell; P V Holland; H Popper
Journal:  Lancet       Date:  1978-03-04       Impact factor: 79.321

View more
  4 in total

1.  Clustering of rare peptide segments in the HCV immunome.

Authors:  Angela Stufano; Giovanni Capone; Barbara Pesetti; Lorenzo Polimeno; Darja Kanduc
Journal:  Self Nonself       Date:  2010-02-03

2.  Development and characterization of a human monoclonal antibody targeting the N-terminal region of hepatitis C virus envelope glycoprotein E1.

Authors:  Ahmed Atef Mesalam; Isabelle Desombere; Ali Farhoudi; Freya Van Houtte; Lieven Verhoye; Jonathan Ball; Jean Dubuisson; Steven K H Foung; Arvind H Patel; Mats A A Persson; Geert Leroux-Roels; Philip Meuleman
Journal:  Virology       Date:  2017-11-10       Impact factor: 3.616

3.  Structure of Hepatitis C Virus Envelope Glycoprotein E1 Antigenic Site 314-324 in Complex with Antibody IGH526.

Authors:  Leopold Kong; Rameshwar U Kadam; Erick Giang; Tinashe B Ruwona; Travis Nieusma; Jeffrey C Culhane; Robyn L Stanfield; Philip E Dawson; Ian A Wilson; Mansun Law
Journal:  J Mol Biol       Date:  2015-06-30       Impact factor: 5.469

4.  Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus.

Authors:  Jean-Christophe Meunier; Rodney S Russell; Vera Goossens; Sofie Priem; Hugo Walter; Erik Depla; Ann Union; Kristina N Faulk; Jens Bukh; Suzanne U Emerson; Robert H Purcell
Journal:  J Virol       Date:  2007-10-31       Impact factor: 5.103

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.